Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial
Description: Randomized, double-blind, placebo-controlled, cross-over design to compare the impacts of a single intranasal oxytocin dose on amygdala connectivity among individuals with schizophrenia (n = 22) versus healthy controls (n = 24).
Related article: http://doi.org/10.1093/schbul/sbz091
Citation guidelines
If you use the data from this collection please include the following persistent identifier in the text of your manuscript:
https://identifiers.org/neurovault.collection:5488
This will help to track the use of this data in the literature. In addition, consider also citing the paper related to this collection.
